Does occupational stereotyping still exist?

Autor: St Pierre R, Herendeen Nm, Nagle Am, Moore Ds

Publikováno v: The Journal of psychology. 128(5)

We surveyed 113 college students regarding their views of certain occupational stereotypes. Our results indicated that in this population gender was related to the subjects' views of occupations as either male, female, or neutral, and that the father

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99c0de04032848f7730174ab7beb65b0
https://pubmed.ncbi.nlm.nih.gov/7983615

Machine-learned molecular mechanics force fields from large-scale quantum chemical data.

Autor: Takaba K; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center New York NY 10065 USA john.chodera@choderalab.org wangyq@wangyq.net.; Pharmaceuticals Research Center, Advanced Drug Discovery, Asahi Kasei Pharma Corporation Shizuoka 410-2321 Japan takaba.kb@om.asahi-kasei.co.jp., Friedman AJ; Department of Chemical and Biological Engineering, University of Colorado Boulder Boulder CO 80309 USA., Cavender CE; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego 9500 Gilman Drive La Jolla CA 92093 USA., Behara PK; Center for Neurotherapeutics, Department of Pathology and Laboratory Medicine, University of California Irvine CA 92697 USA., Pulido I; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center New York NY 10065 USA john.chodera@choderalab.org wangyq@wangyq.net., Henry MM; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center New York NY 10065 USA john.chodera@choderalab.org wangyq@wangyq.net., MacDermott-Opeskin H; Open Molecular Software Foundation Davis CA 95618 USA., Iacovella CR; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center New York NY 10065 USA john.chodera@choderalab.org wangyq@wangyq.net., Nagle AM; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center New York NY 10065 USA john.chodera@choderalab.org wangyq@wangyq.net.; Department of Bioengineering, University of California, Berkeley Berkeley CA 94720 USA., Payne AM; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center New York NY 10065 USA john.chodera@choderalab.org wangyq@wangyq.net.; Tri-Institutional PhD Program in Chemical Biology, Memorial Sloan Kettering Cancer Center New York 10065 USA., Shirts MR; Department of Chemical and Biological Engineering, University of Colorado Boulder Boulder CO 80309 USA., Mobley DL; Department of Pharmaceutical Sciences, University of California Irvine California 92697 USA., Chodera JD; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center New York NY 10065 USA john.chodera@choderalab.org wangyq@wangyq.net., Wang Y; Simons Center for Computational Physical Chemistry and Center for Data Science, New York University New York NY 10004 USA.; Computational and Systems Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center New York NY 10065 USA john.chodera@choderalab.org wangyq@wangyq.net.

Publikováno v: Chemical science [Chem Sci] 2024 Jun 26; Vol. 15 (32), pp. 12861-12878. Date of Electronic Publication: 2024 Jun 26 (Print Publication: 2024).

Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms.

Autor: Goyal G; Division of Hematology, Mayo Clinic, Rochester, MN., Lau D; Tempus Labs, Chicago, IL; and., Nagle AM; Tempus Labs, Chicago, IL; and., Vassallo R; Division of Pulmonary and Critical Care Medicine., Rech KL; Department of Laboratory Medicine and Pathology., Ryu JH; Division of Pulmonary and Critical Care Medicine., Davidge-Pitts CJ; Division of Endocrinology and Metabolism., Tobin WO; Division of Neurology., Koster MJ; Division of Rheumatology, and., Bennani NN; Division of Hematology, Mayo Clinic, Rochester, MN., Shah MV; Division of Hematology, Mayo Clinic, Rochester, MN., Liu MC; Division of Pulmonary and Critical Care Medicine.; Department of Oncology, Mayo Clinic, Rochester, MN., Go RS; Division of Hematology, Mayo Clinic, Rochester, MN.

Publikováno v: Blood [Blood] 2019 Apr 04; Vol. 133 (14), pp. 1607-1610. Date of Electronic Publication: 2019 Jan 29.

Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer.

Autor: Hartmaier RJ; Foundation Medicine Inc., Cambridge; Department of Pharmacology and Chemical Biolog, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, USA; Women's Cancer Research Center, Magee-Women's Research Institute, Pittsburgh, USA. Electronic address: leeav@upmc.edu., Trabucco SE; Foundation Medicine Inc., Cambridge., Priedigkeit N; Department of Pharmacology and Chemical Biolog, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, USA; Women's Cancer Research Center, Magee-Women's Research Institute, Pittsburgh, USA., Chung JH; Foundation Medicine Inc., Cambridge., Parachoniak CA; Foundation Medicine Inc., Cambridge., Vanden Borre P; Foundation Medicine Inc., Cambridge., Morley S; Foundation Medicine Inc., Cambridge., Rosenzweig M; Foundation Medicine Inc., Cambridge., Gay LM; Foundation Medicine Inc., Cambridge., Goldberg ME; Foundation Medicine Inc., Cambridge., Suh J; Foundation Medicine Inc., Cambridge., Ali SM; Foundation Medicine Inc., Cambridge., Ross J; Foundation Medicine Inc., Cambridge., Leyland-Jones B; Department of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, USA., Young B; Department of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, USA., Williams C; Department of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, USA., Park B; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, USA., Tsai M; Minnesota Oncology, Minneapolis, USA., Haley B; UT Southwestern Medical Center, Dallas, USA., Peguero J; Oncology Consultants Research Department, Houston, USA., Callahan RD; UCLA Medical Center, Santa Monica, USA., Sachelarie I; Carlisle Regional Medical Center, Carlisle, USA., Cho J; New Bern Cancer Care, New Bern, USA., Atkinson JM; Women's Cancer Research Center, Magee-Women's Research Institute, Pittsburgh, USA., Bahreini A; Women's Cancer Research Center, Magee-Women's Research Institute, Pittsburgh, USA; Department of Human Genetics, University of Pittsburgh, Pittsburgh, USA; Department of Genetics and Molecular Biology, Isfahan University of Medical Sciences, Isfahan, Iran., Nagle AM; Department of Pharmacology and Chemical Biolog, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, USA; Women's Cancer Research Center, Magee-Women's Research Institute, Pittsburgh, USA., Puhalla SL; Women's Cancer Research Center, Magee-Women's Research Institute, Pittsburgh, USA; Foundation Medicine Inc., Cambridge; Department of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, USA., Watters RJ; Department of Pharmacology and Chemical Biolog, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, USA; Women's Cancer Research Center, Magee-Women's Research Institute, Pittsburgh, USA; Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, USA., Erdogan-Yildirim Z; Women's Cancer Research Center, Magee-Women's Research Institute, Pittsburgh, USA; Department of Human Genetics, University of Pittsburgh, Pittsburgh, USA., Cao L; Women's Cancer Research Center, Magee-Women's Research Institute, Pittsburgh, USA; Central South University Xiangya School of Medicine, China., Oesterreich S; Department of Pharmacology and Chemical Biolog, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, USA; Women's Cancer Research Center, Magee-Women's Research Institute, Pittsburgh, USA., Mathew A; Department of Medicine, University of Pittsburgh, Pittsburgh, USA., Lucas PC; Department of Pathology, University of Pittsburgh, Pittsburgh, USA., Davidson NE; Foundation Medicine Inc., Cambridge; Department of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, USA., Brufsky AM; Foundation Medicine Inc., Cambridge; Department of Molecular and Experimental Medicine, Avera Cancer Institute, Sioux Falls, USA., Frampton GM; Foundation Medicine Inc., Cambridge., Stephens PJ; Foundation Medicine Inc., Cambridge., Chmielecki J; Foundation Medicine Inc., Cambridge., Lee AV; Department of Pharmacology and Chemical Biolog, UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, USA; Women's Cancer Research Center, Magee-Women's Research Institute, Pittsburgh, USA.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2018 Apr 01; Vol. 29 (4), pp. 872-880.

Proteomic Screening and Lasso Regression Reveal Differential Signaling in Insulin and Insulin-like Growth Factor I (IGF1) Pathways.

Autor: Erdem C; From the ‡Department of Computational & Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania; §University of Pittsburgh Drug Discovery Institute, University of Pittsburgh, Pittsburgh, Pennsylvania;, Nagle AM; ¶Department of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania; ‖Women's Cancer Research Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania;, Casa AJ; *Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas;, Litzenburger BC; *Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas;, Wang YF; *Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas;, Taylor DL; From the ‡Department of Computational & Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania; §University of Pittsburgh Drug Discovery Institute, University of Pittsburgh, Pittsburgh, Pennsylvania;, Lee AV; ¶Department of Pharmacology & Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania; ‖Women's Cancer Research Center, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; ‡‡Department of Human Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania., Lezon TR; From the ‡Department of Computational & Systems Biology, University of Pittsburgh, Pittsburgh, Pennsylvania; §University of Pittsburgh Drug Discovery Institute, University of Pittsburgh, Pittsburgh, Pennsylvania; lezon@pitt.edu.

Publikováno v: Molecular & cellular proteomics : MCP [Mol Cell Proteomics] 2016 Sep; Vol. 15 (9), pp. 3045-57. Date of Electronic Publication: 2016 Jun 30.